As HIV-exposed, uninfected infants have higher rates of morbidity and mortality than HIV-unexposed uninfected infants, a study was conducted to analyze whether particular infections or immune responses contribute to hospitalization.
The researchers tested their hypothesis that a decrease in respiratory virus incidence would be associated with a reduction in inappropriate ambulatory antibiotic orders.
A team of investigators sought to estimate the burden of acute respiratory illness in ambulatory care settings for 12 respiratory viruses in Washington state during the 2018-2019 influenza season.
Investigators conducted a systematic review and meta-analysis of 37 studies that used a test-negative design to evaluate IVE against influenza-associated hospitalization in children.
Investigators compared the immunogenicity and safety of the influenza vaccine of different intradermal vaccine doses with a standard intramuscular dose.
Researchers used Medicare claims data to estimate differences in influenza vaccination rates among patients of female vs male physicians.
Researchers assessed the impact on pooled adjusted end-season vaccine effectiveness estimates from outpatient test-negative design studies.
Flucelvax Quadrivalent is a subunit influenza vaccine manufactured using cell derived candidate vaccine viruses; it does not contain egg proteins or antibiotics.
Researchers compared safety, reactogenicity, and changes in Health-Related Quality of Life scores of aIIV3 vs HD-IIV3 flu vaccines in older adults.
Researchers analyzed pooled patient data from 2 hospital-based respiratory virus surveillance cohorts to assess the burden of noninfluenza respiratory virus (NIRV) infection.
